Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | BRAF | P15056 | 4/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 6/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | SMO | Q99835 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5770736 | 0.89 | PTGS2 (0.44) | PTGS2MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL5778310 | 0.80 | POLB (0.51) | PTGS2BRAFMAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL6697312 | 0.78 | FYN (0.38) | BRAFFYNMAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL5774719 | 0.77 | PTGS2 (0.48) | PTGS2MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL5776886 | 0.77 | PTGS2 (0.49) | PTGS2MEN1KMT2ABRAFFYN | |
| SCHEMBL5770740 | 0.75 | SMN1; SMN2 (0.48) | PTGS2MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL5777332 | 0.74 | PTGS2 (0.42) | PTGS2BRAFFYNMAPTALDH1A1 | |
| SCHEMBL5774936 | 0.74 | PTGS2 (0.42) | PTGS2BRAFFYNMAPTALDH1A1 | |
| SCHEMBL6692596 | 0.73 | BRAF (0.40) | MEN1KMT2ABRAFFYNMAPT | |
| SCHEMBL7226348 | 0.73 | PTGS2 (0.45) | PTGS2MEN1KMT2ABRAFFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040077675-A1 | Compounds and methods for inhibiting MRP1 | BONJOUKLIAN ROSANNE (US) | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077675-A1 | Compounds and methods for inhibiting MRP1 | ABCC1, ABCB1, ABCB11 | PTGS2 1354/4885MEN1 1445/4885KMT2A 3995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.